| |
| |
|
| Insider
Information: |
Wheeler Craig A |
| Relationship: |
Director |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
452,764 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$555,646 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
452,764 |
|
|
| Total
Value |
$555,646 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
Director |
2014-02-12 |
400,394 |
2006-02-13 |
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
President & CEO, Direc... |
2020-10-01 |
0 |
2020-10-01 |
0 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
Director |
2023-06-08 |
52,370 |
2017-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2017-11-10 |
4 |
AS |
$13.25 |
$24,539 |
D/D |
(1,852) |
258,602 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2017-11-21 |
4 |
AS |
$13.34 |
$54,928 |
D/D |
(4,116) |
252,401 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-01-02 |
4 |
AS |
$14.10 |
$141,000 |
I/I |
(10,000) |
324,690 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-01-02 |
4 |
AS |
$14.11 |
$362,147 |
D/D |
(25,666) |
252,401 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-01-02 |
4 |
OE |
$7.41 |
$190,185 |
D/D |
25,666 |
278,067 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-02-08 |
4 |
AS |
$15.89 |
$165,351 |
D/D |
(10,406) |
260,486 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,125 |
275,526 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-02-12 |
4 |
AS |
$16.18 |
$28,687 |
D/D |
(1,773) |
258,713 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-02-14 |
4 |
AS |
$16.14 |
$272,363 |
D/D |
(16,875) |
241,838 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-02-21 |
4 |
AS |
$16.45 |
$64,800 |
D/D |
(3,938) |
237,900 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-04-10 |
4 |
OE |
$10.43 |
$347,674 |
D/D |
33,334 |
230,913 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-04-10 |
4 |
AS |
$19.00 |
$633,346 |
D/D |
(33,334) |
197,579 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-04-10 |
4 |
AS |
$19.00 |
$190,000 |
I/I |
(10,000) |
359,645 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-04-19 |
4 |
AS |
$21.00 |
$104,916 |
I/I |
(4,996) |
354,649 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-04-19 |
4 |
AS |
$21.00 |
$18,900 |
D/D |
(900) |
197,579 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-04-19 |
4 |
OE |
$10.43 |
$9,387 |
D/D |
900 |
198,479 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-01 |
4 |
OE |
$10.43 |
$338,276 |
D/D |
32,433 |
230,012 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-01 |
4 |
AS |
$20.68 |
$670,714 |
D/D |
(32,433) |
197,579 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-01 |
4 |
AS |
$20.75 |
$103,833 |
I/I |
(5,004) |
349,645 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-02 |
4 |
AS |
$21.00 |
$210,000 |
I/I |
(10,000) |
339,645 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-02 |
4 |
AS |
$21.00 |
$699,993 |
D/D |
(33,333) |
197,579 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-02 |
4 |
OE |
$10.43 |
$347,663 |
D/D |
33,333 |
230,912 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-08 |
4 |
AS |
$20.21 |
$52,566 |
D/D |
(2,601) |
200,759 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,781 |
203,360 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEO |
• • – |
2018-05-10 |
4 |
AS |
$21.86 |
$38,736 |
D/D |
(1,772) |
198,987 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
